Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australian Consumer Group Doubts Glucosamine Good For Arthritis

This article was originally published in PharmAsia News

Executive Summary

A consumer group's review of glucosamine products sold in Australia found many lacked enough of the active ingredient to be effective in treating arthritis. The group Choice also said clinical trials so far have not proved glucosamine to be an effective treatment. The group said it studied 26 products containing the ingredient derived from crustacean shells and noted many trials on it have found placebos to be just as effective. Australian regulations set the amount of active ingredient per tablet or capsule. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068419

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel